Drug application
ISOPAQUE 440 (CALCIUM METRIZOATE, MEGLUMINE METRIZOATE, METRIZOATE MAGNESIUM and 1 more)
Drugs@FDA NDA 016847 · GE HEALTHCARE
Key facts
| Drug name | ISOPAQUE 440 |
|---|---|
| Active ingredients | CALCIUM METRIZOATE, MEGLUMINE METRIZOATE, METRIZOATE MAGNESIUM, METRIZOATE SODIUM |
| Application type | NDA |
| Application number | 016847 |
| Company | GE HEALTHCARE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 2 New Active Ingredient and Type 4 New Combination |
| Latest submission status date | Nov 17, 1973 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.